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Abstract This Position Paper was prepared by members of
the Task Force on Global Food Security of the International
Society for Plant Pathology. An objective approach is pro-
posed to the assessment of the potential of genetic modifica-
tion (GM) to reduce the impact of crop diseases. The addition
of GM to the plant breeder’s conventional toolbox facilitates
gene-by-gene introduction into breeding programmes of well-
defined characters, while also allowing access to genes from a
greatly extended range of organisms. The current status of
GM crops is outlined. GM could make an additional contri-
bution to food security but its potential has been controversial,
sometimes because of fixed views that GM is unnatural and
risky. These have no factual basis: GM technology, where
adopted, is widely regulated and no evidence has been report-
ed of adverse consequences for human health. The potential
benefits of GM could be particularly valuable for the devel-
oping world but there are numerous constraints. These include
cost, inadequate seed supply systems, reluctance to adopt
This Position Paper was prepared by members of the Task Force on
Global Food Security (http://www.isppweb.org/foodsecurity_tf.asp) of
the International Society for Plant Pathology.
A Position Paper of the Task Force on Global Food Security is a factual
summary of the principal aspects of a topic, from the perspective of plant
pathology, to present a position from which the merits and drawbacks of
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unfamiliar technology, concern about markets, inadequacy of
local regulatory systems, mismatch between research and
growers’ needs, and limited technical resources. The lower
cost of new gene-editing methods should open the practice of
GM beyond multinational corporations. As yet there are few
examples of utilization of GM-based resistance to plant diseases.
Two cases, papaya ringspot virus and banana xanthomonas wilt,
are outlined. In the developing world there are many more po-
tential cases whose progress is prevented by the absence of ad-
equate biosafety regulation. It is concluded that there is untapped
potential for using GM to introduce disease resistance. An
objective approach to mobilizing this potential is recommended,
to address the severe impact of plant disease on food security.
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Initial statement
The ISPP Task Force on Global Food Security recognizes the
potential of genetic modification (GM) to reduce the impact of
plant diseases on the productivity, safety and quality of crops
in agriculture, horticulture and forestry, and advocates an ob-
jective approach to the assessment of that potential.
Definition
Genetic modification (GM), also known as genetic engineer-
ing, is here defined as alteration of the genetic material of a
plant through human intervention using methods other than
cross-fertilization. The products of genetic modification are
referred to here as genetically modified (GM) plants.
Food security, plant diseases and the value of plant
breeding
Global crop production needs to be substantially increased to
meet the demands of a growing population. Of the population
of more than 7 billion people, some 800 million do not have
enough to eat today. The vast majority of these people live in
developing countries (FAO 2015). By 2050, the global popula-
tion is expected to exceed 9 billion (US Census Bureau 2015).
It has been estimated that some 15 % of global food production
is lost to plant disease (Oerke and Dehne 2008). In developing
countries losses might be much higher. Plant pathologists can-
not ignore the juxtaposition of these figures for food shortage
and the damage to food production caused by plant pathogens.
The impact of plant diseases is exacerbated by increasing
globalization and trade, which facilitate the spread of
pathogens and the emergence of new plant diseases, and by
the need for crops to be grown more intensively as global
population grows with only limited opportunities for increas-
ing the area of cultivated land.
Management of plant diseases can be effected through crop
husbandry and phytosanitary measures, through the use of
pesticides, and through plant breeding. But these measures
have limitations: for example the diversity of pesticides is
declining under more rigorous regulatory control, and resis-
tance to pesticides is increasing. New disease management
methodologies are needed in compensation.
Genetic improvement of crop plants by selective breeding
presents a particularly cost-effective and easily adopted means
of disease management, as the only action required of the
grower is to use appropriate seed or other planting material
(Evenson and Gollin 2003).
Genetic improvement of plants has been practised since the
beginning of agriculture through selection of improved vari-
ants, occurring either spontaneously or amongst the progeny
of cross-breeding, or sometimes through treatment to induce
mutations. The normal multiplication processes of crops then
allow stocks of improved cultivars to be built up.
Conventional plant breeding, which is the basis of nearly
all modern crop cultivars, has been typified as Bcrossing the
best with the best and hoping for the best^. For all its limita-
tions and despite the typical uncertainty of what genetic
change is actually responsible for the improved performance
of its products, plant breeding retains its importance and ac-
ceptance as a key element in crop husbandry (Tester and
Langridge 2010). It is taken for granted as a central and safe
man-made contribution to food security and has a special im-
portance in the development of cultivars with improved resis-
tance to crop pests and diseases.
GM as a tool for plant breeding
The plant breeder’s toolbox traditionally contained devices for
effecting hybridization between stocks of promising plant ma-
terial for cross-breeding, and systems of selection of improved
variants among progeny for multiplication. The versatility of
the toolbox has been greatly increased by the tools of genetic
modification (GM). GM facilitates gene-by-gene introduction
into breeding programmes of well-defined characters, while
also allowing access to genes from a greatly extended range of
organisms since there is no reliance on compatibility in hy-
bridization. Not only is the pool of available variation enor-
mously increased (notably for resistance to pathogens) but far
greater precision is achievable in the introduction of each de-
sirable genetic trait, without other unwanted genes.
Furthermore the release of unwanted variation through genetic
recombination that is an inherent feature of hybridization is
avoided. Consequently the time needed to breed improved
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cultivars bearing specific traits is shortened. It should be rec-
ognized, however, that the cost to a breeder of acquiring GM
capability is likely to be significant. GM as defined here in-
cludes the use of gene-editing tools such as CRISPRs
(Ledford 2015).
The current status of GM crops
GM crops were first used in agriculture in 1996 when 1.7
million hectares were planted (James 2015). There has been
an increasing trend since then, to a total of 180 million hect-
ares in 2015, principally of four crops: soybean, maize, cotton
and oilseed rape (canola). Of the 28 countries in which GM
crops have been deployed, 20 are developing countries. The
principal traits introduced into GM crops up to 2015 are tol-
erance of the herbicide glyphosate, and resistance to insects
from Bacillus thuringiensis. New GM crops of the principal
four species and also potato, beans, eggplant, papaya, squash,
sugar beet, eucalyptus, poplar and apple are now being devel-
oped with these characters, and with drought tolerance, dis-
ease resistance, salt tolerance, nitrogen use efficiency, speed of
ripening, storage quality, nutritional versatility and other char-
acteristics. Field trials of GM potato are being conducted in
Bangladesh, India, Indonesia and Uganda to assess their resis-
tance to late blight, caused by Phytophthora infestans.
Reservations about the safety of GM crops continue to limit
their use, notably in Europe where a majority of the Member
States of the European Union have opted to prohibit their
cultivation (European Commission 2015).
Benefits and risks
There is a strong case for exploring the use of such potentially
valuable tools which present new possibilities to meet the
challenge of food security, extending the widely valued prac-
tice of plant breeding. Nevertheless, the potential of GM for
crop improvement has been the subject of much controversy,
sometimes based on fixed views that GM is unlike other tools
in being unnatural and inherently risky. Thus it has been ar-
gued that the widespread use of GM to introduce insect resis-
tance derived from the bacterium Bacillus thuringiensis (Bt)
into crops brings with it the risk of selection in insect popula-
tions for the capacity to thrive in the presence of the genetic
resistance. Furthermore this could apply to non-target insects
as well as those that are the target of the breeding programme.
Such risks have been ascribed to the use of GM but are in fact
a consequence of deploying the trait, not the technology used
to introduce it.
The choice of traits for introduction byGM should bemade
with due consideration for the consequences of their deploy-
ment. There seems however to be no factual basis to support
the contention that GM technology per se is more likely than
conventional plant breeding to create dangerous new pheno-
types. Indeed the reverse can be argued, since GM should
allow far greater control over genetic change than convention-
al breeding.
As a precaution against risk, the use of GM technology
is officially regulated in most countries, at the laboratory
level and in the deployment of the products of GM in
agriculture. Such regulation may need to be rationalized,
for example in some countries where it precludes research
on GM or the deployment of research outputs, or in others
that lack robust objective oversight. However, the value of
appropriate and proportionate regulation of GM is widely
recognized.
No evidence has been reported of adverse consequences for
human health from consuming the products of crops devel-
oped using GM technology (World Health Organization 2014;
Suzie et al. 2008; National Academies of Sciences,
Engineering, and Medicine 2016). This fact is based on a
substantial and growing body of scientific publications.
There is a case for adoption of a system of objective collec-
tion, evaluation and dissemination of such evidence as a pre-
caution against misleading assertions of risk.
Concerns have been raised about the impact of GM on the
environment, though these are often associated with the intro-
duced trait rather than with the use of GM to introduce it.
However, there is also evidence of environmental benefit, for
example through reduced pesticide use and (with herbicide-
tolerant cultivars) conservation tillage (Sanvido et al. 2007).
Evidence-based evaluation
Decisionmaking on the use of GM, like decision making on any
other technology for plant disease management, should be
based on scientific evidence through critical and independent
evaluation of potential cost/benefit on a case-by-case basis,
taking into consideration economic, social and environmental
issues. There is not yet an accepted structure for such evalua-
tion, which should be rigorously science-based, and should
preferably involve the public in its development and use.
Such a structure would facilitate evidence-based decisions.
GM in the developing world
The potential benefits of GM-based cultivars in disease man-
agement could be considerable in the developing world. There
are however many constraints to be overcome (Adenle et al.
2013), including:
– The high cost of development and deployment of GM-
based cultivars. Because costs must be recouped,
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developers focus on major traits in globally significant
crops.1**
– Inadequate capacity of local seed supply systems to mul-
tiply GM seed.
– Growers’ reluctance to adopt an unfamiliar technology
that may be costly, may require seed to be sourced exter-
nally, and may evoke unfounded perceptions of risk.
– Concern among growers that GM produce may be diffi-
cult to sell, for example to EU countries.
– The challenge of establishing regulatory systems, and
deploying GM in farming systems that differ from those in
developed countries where the technology was developed.
– Discrepancy between the priorities of donor-funded re-
search and the needs of growers.
– Limited local research capacity to identify pathogens and
their variants as targets for development of GM cultivars.
– The need to manage GM introductions to minimize po-
tential build-up of pathogen virulence and avoid acciden-
tal transfer of traits to weed species.
– The risk to GM developers of legal liability for accidental
introduction of GM material into food chains designated
as non-GM.
– The need for effective seed production and distribution
systems to avoid proliferation of poor quality or fake GM
products.
Examples of GM-based disease resistance
To date, there are few examples of utilization of GM-based
resistance to plant diseases. Two cases are outlined here. A
basis for evaluating other prospects has been discussed
(Collinge et al. 2016).
In Hawaii in the 1990s, the increasingly severe effects of
papaya ringspot virus (PRSV) were addressed by develop-
ment of GM papaya cultivars with resistance based on the
introduction of coat protein (CP) genes from mild strains of
the pathogen (Tripathi et al. 2008; Fermin et al. 2010).
Approval for their cultivation in Hawaii was granted by US
Government agencies. Their resistance to PRSV was substan-
tial and has enabled production of papaya to continue in
Hawaii, where it had been threatened. The GM produce is
widely sold locally and exported. Like any other kind of re-
sistance, it may be rendered less effective by the emergence of
virulent strains of the pathogen. But as its efficacy is greater
when the introduced CP gene is derived from locally damag-
ing strains, there is scope for adapting the GM crop to the local
pathogen challenge. Papaya cultivars with CP and other GM-
based forms of resistance to PRSV are now available for cul-
tivation in other regions. Their utilization is limited mainly by
reluctance to adopt GM technology.
Some other cases are less successful (Tripathi et al. 2009). In
East Africa the banana cropmay be seriously affected by banana
xanthomonas wilt (BXW) caused by the bacterium
Xanthomonas campestris pv. musacearum, which has spread
invasively since 2001. Yield may be reduced by 90 % within
a year of infection. This is a new disease and is of critical eco-
nomic and social importance in Uganda where banana is the
staple crop. Banana cultivars show no resistance to the disease,
so the International Institute of Tropical Agriculture (IITA), with
national and African partners, developed GM bananas express-
ing the Hrap or Pflp genes from Capsicum annuum. These
exhibited strong resistance to BXWin laboratory tests. Themost
resistant lines were planted in a Confined Field Trial (CFT) after
approval from the National Biosafety Committee. They are
however unable to progress further because official biosafety
regulation has not been established in Uganda. Attempts to pass
new legislation have been stalled by campaigns suggesting
health risks and the likelihood of market collapse.
There are many such examples of experimental GM-based
lines in developing countries that are prevented from
progressing beyond the CFT stage by the need for effective
biosafety regulation, which would allow evidence-based con-
sideration of benefits and risks (Bailey et al. 2014).
Conclusion
The ISPP Task Force on Global Food Security considers that
there is untapped potential for using GM to introduce resis-
tance to more pathogens in a wider variety of crops. The Task
Force advocates an objective approach to assessment and
application of the potential of GM, as one means of address-
ing the severe impact of plant disease on food security.
More detailed treatment of the topic can be found here
(Bennett and Jennings 2014; Qaim 2015; Collinge 2016;
National Academies of Sciences, Engineering, and Medicine
2016).
1 ** At present, the costs are such that the choice of GM for disease
management in developing countries should be critically compared with
alternative strategies for cost effectiveness. The products of commercial
investment may however be locally available: for example the African
Agricultural Technology Foundation introduces genes donated by multi-
nationals into African varieties and provides farmers with assistance in
using them (Delmer et al. 2003). The lower cost of new gene-editing
methods should open the practice of GM beyond multinational corpora-
tions, reducing the constraint to focus on major crops and increasing the
scope for small companies and academic researchers to develop GM
cultivars (Ledford 2015).
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